You will lead a ground-breaking scientific program addressing basic research questions with a pronounced translational potential. You have a collaborative mindset that will allow you to build bridges between existing research groups at VIB and KU Leuven, as well as with other academic centers and the industry. You will focus on novel omics technologies with a research-specific focus on oncology and an unmet patient need.
We are particularly interested in researchers working on the cross-talk between tumors and various components of the tumor microenvironment including (but not limited to) the vasculature, immune and/or nervous system. The candidate may have a focus on various mechanisms of cross-talks involving paracrine and/or juxtacrine signaling. Ideally, the candidate will develop and/or make use of innovative reductionist (i.e. 3D tumoroid models) or in vivo models (i.e. mouse genetics, in vivo lineage tracing, PDXs,…) and establish clinical relevance using human clinical samples.
A dedicated focus on a specific cancer indication (i.e. brain tumors, pancreatic cancer, ….) and/or underlying biological process (metastatic dissemination, lymph node involvement, circulating tumor cells, specific tumor & micro-environment interactions etc.) is considered a plus.
Belgium Biology Biomedical and Physiology Biotechnology and Genetics Not for Profit On-site VIB